Suppr超能文献

长期口服盐酸西曲酸酯对Wistar大鼠实验性诱导肠化生的抑制作用。

Inhibitory effect of prolonged oral administration of cetraxate hydrochloride on experimentally-induced intestinal metaplasia in Wistar rats.

作者信息

Tatsuta M, Yamamura H, Iishi H, Taniguchi H

机构信息

Department of Gastrointestinal Oncology, Center for Adult Diseases, Osaka, Japan.

出版信息

Arzneimittelforschung. 1987 Sep;37(9):1045-8.

PMID:3435599
Abstract

The effect of cetraxate hydrochloride (Neuer) on the induction of intestinal metaplasia by intragastric instillation of 5% NaOH solution was investigated in Wistar rats. Oral administration of cetraxate, beginning 2 days after NaOH treatment, resulted in a significant increase in antral mucosal blood flow and a significant reduction in the incidence and amount of intestinal metaplasia in experimental week 25, but no significant changes in basal acid secretion or antral mucosal pH. On histological examination, goblet cell metaplasia were frequently seen. These results show that the increased gastric blood flow produced by cetraxate hydrochloride may be associated with the suppression of induction of intestinal metaplasias.

摘要

在Wistar大鼠中研究了盐酸西曲酸酯(Neuer)对通过胃内滴注5%氢氧化钠溶液诱导肠化生的影响。在氢氧化钠处理后2天开始口服西曲酸酯,在实验第25周时,胃窦黏膜血流量显著增加,肠化生的发生率和程度显著降低,但基础胃酸分泌或胃窦黏膜pH值无显著变化。组织学检查时,常见杯状细胞化生。这些结果表明,盐酸西曲酸酯产生的胃血流量增加可能与肠化生诱导的抑制有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验